A review of electromagnetic frequency modulation, with a focus on eMedica as a therapeutic approach for Parkinson's disease, that goes beyond pharmaceutical treatments

Abstract

Parkinson’s disease (PD) is a chronic neurodegenerative disorder characterized by motor and non-motor symptoms that significantly impact the quality of life of those affected. Current management strategies encompass pharmacological treatments, physiotherapy, and lifestyle modifications. However, these methods often yield limited benefits and do not address the underlying disease mechanisms. This review explores the potential of the Electromagnetic Frequency Modulation device, eMedica, as an innovative therapeutic strategy for enhanced management of PD. Through a review of existing literature on electromagnetic therapy, neuroprotection, and the specific applications of eMedica, this paper proposes a multidisciplinary approach that leverages new technology to improve PD outcomes.